Raymond James analyst Jonathan Hughes reiterated a Buy rating on Omega Healthcare (NYSE:OHI) on Friday, setting a price target of $40, which is approximately 9.59% above the present share price of $36.5.
Hughes expects Omega Healthcare to post earnings per share (EPS) of $0.69 for the second quarter of 2021.
The current consensus among 3 TipRanks analysts is for a Moderate Buy rating of shares in Omega Healthcare, with an average price target of $39.67.
The analysts price targets range from a high of $42 to a low of $37.
In its latest earnings report, released on 03/31/2021, the company reported a quarterly revenue of $273.77 million and a net profit of $171.06 million. The company's market cap is $8.59 billion.
According to TipRanks.com, Raymond James analyst Jonathan Hughes is currently ranked with 4 stars on a 0-5 stars ranking scale, with an average return of 10.9% and a 63.74% success rate.
Omega Healthcare Investors, Inc. engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities. Its portfolio consists of long-term leases and mortgage agreements. The company was founded on March 31, 1992 and is headquartered in Hunt Valley, MD.